1. Home
  2. CPRX vs CLSK Comparison

CPRX vs CLSK Comparison

Compare CPRX & CLSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
    SELLHOLDBUYas of 2 days ago
  • CLSK
    SELLHOLDBUYas of 2 days ago
  • Stock Information
  • Founded
  • CPRX 2002
  • CLSK 1987
  • Country
  • CPRX United States
  • CLSK United States
  • Employees
  • CPRX N/A
  • CLSK N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • CLSK Finance: Consumer Services
  • Sector
  • CPRX Health Care
  • CLSK Finance
  • Exchange
  • CPRX Nasdaq
  • CLSK Nasdaq
  • Market Cap
  • CPRX 2.6B
  • CLSK 2.2B
  • IPO Year
  • CPRX 2006
  • CLSK N/A
  • Fundamental
  • Price
  • CPRX $24.69
  • CLSK $7.19
  • Analyst Decision
  • CPRX Strong Buy
  • CLSK Strong Buy
  • Analyst Count
  • CPRX 8
  • CLSK 8
  • Target Price
  • CPRX $32.50
  • CLSK $21.71
  • AVG Volume (30 Days)
  • CPRX 1.5M
  • CLSK 27.2M
  • Earning Date
  • CPRX 05-07-2025
  • CLSK 05-08-2025
  • Dividend Yield
  • CPRX N/A
  • CLSK N/A
  • EPS Growth
  • CPRX 107.94
  • CLSK N/A
  • EPS
  • CPRX 1.31
  • CLSK 0.27
  • Revenue
  • CPRX $491,734,000.00
  • CLSK $467,488,000.00
  • Revenue This Year
  • CPRX $15.17
  • CLSK $146.07
  • Revenue Next Year
  • CPRX $8.28
  • CLSK $38.23
  • P/E Ratio
  • CPRX $18.85
  • CLSK $26.32
  • Revenue Growth
  • CPRX 23.49
  • CLSK 118.07
  • 52 Week Low
  • CPRX $14.47
  • CLSK $7.02
  • 52 Week High
  • CPRX $26.16
  • CLSK $21.39
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 62.78
  • CLSK 39.60
  • Support Level
  • CPRX $20.68
  • CLSK $7.27
  • Resistance Level
  • CPRX $26.16
  • CLSK $8.90
  • Average True Range (ATR)
  • CPRX 0.83
  • CLSK 0.66
  • MACD
  • CPRX 0.36
  • CLSK 0.05
  • Stochastic Oscillator
  • CPRX 75.21
  • CLSK 9.04

Stock Price Comparison Chart: CPRX vs CLSK

CPRX
CLSK
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025024681012141618202224262830CPRX VS CLSK

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.

About CLSK CleanSpark Inc.

Cleanspark Inc is a bitcoin mining company. Through CleanSpark, Inc., and the Company's wholly owned subsidiaries, the company mines bitcoin. The company entered the bitcoin mining industry through its acquisition of ATL. Bitcoin mining is the sole reportable segment of the company.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use